ArticleOPEN ACCESS

IFNα Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk

Cancer discovery
DOI: 10.1158/2159-8290.CD-22-0472
4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

SUMMARY: In this issue, Hu and colleagues unveil that IFNα administration combined with anti-PD-1 therapy can potentiate murine and human CD8+ T-cell antitumor response in hepatocellular carcinoma, highlighting a novel therapeutic strategy for hepatocellular carcinoma. See related article by Hu et al., p. 1718 (6) .

Cite

CITATION STYLE

APA

Kao, K. C., Jaccard, A., & Ho, P. C. (2022, July 6). IFNα Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk. Cancer Discovery. NLM (Medline). https://doi.org/10.1158/2159-8290.CD-22-0472

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free